GleanMark

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET Trademark

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET is a USPTO trademark filed by IPSEN PHARMA S.A.S.. Status: Cancelled.

Trademark Facts

MarkCLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET
Serial Number79080475
Registration Number4033261
StatusCancelled
Filing Date2010-02-15
Registration Date2011-10-04
Mark TypeWord
Nice Classes042 (Software & IT)
OwnerIPSEN PHARMA S.A.S.
Attorney of RecordWilliam S. Frommer & Marilyn M. Brogan
Prosecution Events40
Latest EventDENC on 2020-09-04

Goods & Services

"CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET"

Related